InsuQuick VDPen

InsuQuick VDPen is designed for subcutaneous injection and is suitable for use in adults, adolescents, and children with type 1 diabetes, as well as adults with type 2 diabetes requiring insulin therapy. The prefilled, variable-dose pen device offers precise dosing flexibility, enhancing patient adherence and convenience. Dosage and administration should be individualized based on patient’s metabolic needs, blood glucose monitoring results, and glycemic control goals.

InsuQuick VDPen should be used in conjunction with appropriate dietary measures and physical activity. Caution is advised to avoid hypoglycemia, the most common adverse effect. Proper injection technique and site rotation are recommended to minimize local reactions. Patients should be educated on recognizing and managing hypoglycemia and the importance of adherence to prescribed regimens for optimal therapeutic outcomes.